BN
Boddupally Naresh
About Boddupally Naresh
Data last updated:
Boddupally Naresh is a Director at Priscilla Lifesciences Private Limited (since 2023). The company operates in Pharma. Priscilla Lifesciences Private Limited reported revenue of ₹9.9 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Priscilla Lifesciences Private Limited U47721DL2023PTC415147 | Director | 01 Jun 2023 | 2023 | ₹9.9 Lakh (FY 2024) | Active |
Board colleagues of Boddupally Naresh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ravi Katkuri | 10187730 | Priscilla Lifesciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Boddupally Naresh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Boddupally Naresh
Boddupally Naresh currently holds 1 directorship: Priscilla Lifesciences Private Limited (Director, since 01 Jun 2023, revenue ₹9.9 Lakh (FY 2024)).
Boddupally Naresh was first appointed on 01 Jun 2023 as Director at Priscilla Lifesciences Private Limited.
The current boards of Boddupally Naresh's companies include Ravi Katkuri (Priscilla Lifesciences Private Limited).